Economy
Durable Goods Orders
U.S. Durable Goods orders grew again after dipping in the last month, but orders excluding volatile transportation sector decreased. That category excludes defense and transportation and gives a better indication of longer-term trends in the private sector.
Durable goods shipments by industry
Durable goods new orders by industry
|
Factory Orders
U.S. Factory orders grew again after dipping in the last month, but Shipments of durable goods fell by -0.73 % to $543 billions.
Factory shipments by industry
Factory new orders by industry
|
Gross Domestic Product
U.S. economy grows to an annual rate of 2.6 %, as the U.S. trade balance improves.
|
|
|
Recently Reported Results |
Candel Therapeutics Inc
Shifting our regard towards the most recent fiscal period CADL Losses have widen at $-0.15 per share, relative to the recent numbers of $1.54 per share a year ago financial reporting period, In the preceding financial reporting period CADL realized $-0.30 per share.
Candel Therapeutics Inc Suppliers
Candel Therapeutics Inc Suppliers
|
Invesco Db G10 Currency Harvest Fund
In the fourth quarter of 2022 financial report company reached break-even at $0.00 per share, opposite of $0.00 per share a year before financial reporting period, In the prior financial reporting period Invesco Db G10 Currency Harvest Fund realized $0.00 per share.
Invesco Db G10 Currency Harvest Fund stock quotes, charts, profile
Invesco Db G10 Currency Harvest Fund Income Statement, Balance sheets, Cash Flow Statement
|
Galaxy Gaming Inc
For the October to December 31 2022 GLXZ realized net deficit per share of $0.00 in contrast to $0.02 a year ago, while Revenues advanced by 4.764 % to $5.94 millions from the similar quarter a year ago.
Galaxy Gaming Inc stock quotes, charts, profile
Galaxy Gaming Inc Suppliers
|
Calithera Biosciences Inc
The Major Pharmaceutical Preparations industry advisors continue to interpret the fourth quarter of 2022 performance. Presently those advisors follow operating shortfall of $-7.346 millions, from the CALA, as it has not specified any revenue so far, for the own October to December 31 2022 financial reporting period.
Calithera Biosciences Inc Competitors, Market Share
Calithera Biosciences Inc Income Statement, Balance sheets, Cash Flow Statement
|
Vantage Drilling International
Strong Revenue growth in the fourth quarter of 2022, by 52.984 % to $76.19 millions fueled to cut losses to $-1.33 per share, from $-1.79 in similar the reporting period a year prior.
Vantage Drilling International Suppliers
Vantage Drilling International growth Rates, Profitability, PE
|
Surrozen Inc
the Biotechnology & Pharmaceuticals company disclosed $12.5 millions, in Revenue in the fiscal period closing December 31 2022.
Surrozen Inc Suppliers
Surrozen Inc Income Statement, Balance sheets, Cash Flow Statement
|
|
|
|
Recently Reported Results |
Aei Income And Growth Fund Xxi Limited Partnership
For the fiscal period ending December 31 2022 NONE profits turned positive of $0.01 per share compare to $-0.14 a year prior and earnings per share dropped by -99.63 % from $1.64 per share from the previous quarter.
Revenues faded by -37.649 % to $0.19 millions from $0.31 millions in the corresponding quarter a year prior and sequentially Revenue Tumbled by -49.218 % from $0.38 millions.
Aei Income And Growth Fund Xxi Limited Partnership Customers
Aei Income And Growth Fund Xxi Limited Partnership Revenue rise Rates
|
Industrial production
Production by industry
Capacity utilization by industry
|
Better Therapeutics Inc
While the earnings cycle of fiscal October to December 31 2022 season goes on, countless companies have announced their results. Among them, have been multiple constituents of the Medical Equipment & Supplies industry. And now, BTTX disclosed operating deficit of $-8.322 millions, for the financial period ending December 31 2022.
Better Therapeutics Inc stock quotes, charts, profile
Better Therapeutics Inc elevation Rates, Profitability, PE
|
Aptevo Therapeutics Inc
For the fourth quarter of 2022 APVO decreased a loss per share of $-0.84 per share compare to $-1.28 a year before and Income per Share improved from $-1.50 per share from the previous reporting period.
Revenues remained unchanged to $0.00 millions from $3.67 millions in the corresponding reporting period a year before and sequentially Revenue Tumbled from $0.00 millions.
Aptevo Therapeutics Inc stock quotes, charts, profile
Aptevo Therapeutics Inc advance Rates, Profitability, PE
|
Candel Therapeutics Inc
Focusing on the fourth quarter of 2022 the Biotechnology & Pharmaceuticals company Diminishing Returns have swelled at $-0.15 per share, relative to the earnings of $1.54 per share a year prior quarter, In the prior quarter the Candel Therapeutics Inc realized $-0.30 per share.
Candel Therapeutics Inc Suppliers
Candel Therapeutics Inc Income Statement, Balance sheets, Cash Flow Statement
|
Producer Price Index
Prices increased on the faster pace again, adding to inflationary worries.
|
Personal Income and Spending
|
Auto Sales
|
Invesco Db G10 Currency Harvest Fund
In the October to December 31 2022 company reached zero gain at $0.00 per share, opposite of $0.00 per share a year ago reporting period, In the previous reporting period Invesco Db G10 Currency Harvest Fund realized $0.00 per share.
Invesco Db G10 Currency Harvest Fund Customers
Invesco Db G10 Currency Harvest Fund Suppliers
|
Galaxy Gaming Inc
For the October to December 31 2022 company realized a shortfall per share of $0.00 compared to $0.02 a year ago, while Revenues advanced by 4.764 % to $5.94 millions from the comparable quarter a year ago.
Galaxy Gaming Inc stock quotes, charts, profile
Galaxy Gaming Inc growth Rates, Profitability, PE
|
Calithera Biosciences Inc
After the big players in the Major Pharmaceutical Preparations sector, a number of overlooked corporations are coming in with the earnings. CALA told it has announced operating shortfall of $-7.346 millions, for the fourth quarter of 2022.
Calithera Biosciences Inc Customers
Calithera Biosciences Inc Income Statement, Balance sheets, Cash Flow Statement
|
Vantage Drilling International
Respectable Revenue elevation in the Dec 31 2022 report, by 52.984 % to $76.19 millions supported to cut losses to $-1.33 per share, from $-1.79 in comparable the quarter a year prior.
Vantage Drilling International Competitors, Market Share
Vantage Drilling International Income Statement, Balance sheets, Cash Flow Statement
|
Surrozen Inc
Surrozen Inc disclosed $12.5 millions, in Revenue in the most recent fiscal period.
Surrozen Inc stock quotes, charts, profile
Surrozen Inc Suppliers
|
Ast Spacemobile Inc
Considering the financial span closing Dec 31 2022 the Communications Services company reached 0 at $0.00 per share, relative to the recent numbers of $0.32 per share a year before financial reporting period, In the preceding financial reporting period the Ast Spacemobile Inc realized $-0.18 per share.
Ast Spacemobile Inc Competitors, Market Share
Ast Spacemobile Inc Income Statement, Balance sheets, Cash Flow Statement
|
|
|
|
|